Research Letter
Abstract
We addressed the limitations of subjective clinical tremor assessment by comparing routine neurological evaluation with a Tremor Occurrence Score derived from smartwatch sensor data, among 142 participants with Parkinson disease and 77 healthy controls. Our findings highlight the potential of smartwatches for automated tremor detection as a valuable addition to conventional assessments, applicable in both clinical and home settings.
JMIR Form Res 2024;8:e51249doi:10.2196/51249
Keywords
Introduction
Clinical assessment of tremor is limited by its subjectivity, making it challenging to detect subtle tremors (<0.05 g) [
]. The need for technology-based evaluations led to extensive research on sensor-based tremor assessments [ - ]. However, the benefits of smart consumer devices for clinical documentation remain unaddressed. We aimed to bridge this research gap by comparing tremor documentation from routine neurological assessments with a Tremor Occurrence Score (TOS) derived from smartwatch sensor recordings. We included 142 participants with Parkinson disease (PD) and 77 healthy controls. During clinical visits, routine neurological assessments were conducted and wrist-motion data were captured using a previously established Smart Device System (SDS) in a controlled setting [ , ]. The SDS is based on consumer smartwatches and smartphones. The smartwatches were validated in a geophysical experiment for tremor analysis with comparison to a gold-standard seismometer [ ]. We investigated the potential of complementing routine tremor documentation with tremor capture using smartwatches [ ].Methods
Overview
The SDS parent study [
] recruited 450 participants, including patients with PD and other movement disorders and healthy controls. The SDS implemented data capture through electronic questionnaires and app-guided movement tasks with smartwatch sensing. Varghese et al [ ] provide a detailed description of the study. Of the 450 participants, 101 were excluded due to diagnoses other than PD. Moreover, 130 patients with PD without explicit information regarding tremor in routine documentation were excluded, resulting in 219 participants. summarizes the age, sex, and years from diagnosis onset distribution.Characteristics | PDa cohort (n=142) | HCb cohort (n=77) | P value | ||||||
Sex, n (%) | <.001 | ||||||||
Female | 42 (29.6) | 48 (62.3) | |||||||
Male | 100 (70.4) | 29 (37.7) | |||||||
Age (y), mean (SD) | 64.9 (9.4) | 62.6 (12.4) | .08 | ||||||
Years from diagnosis onset | N/Ac | ||||||||
Mean (SD) | 6.70 (5.36) | N/A | |||||||
Range, n (%) | |||||||||
0-4 | 60 (42.2) | N/A | |||||||
5-9 | 39 (27.5) | N/A | |||||||
10-14 | 31 (21.8) | N/A | |||||||
15-19 | 6 (4.2) | N/A | |||||||
≥20 | 6 (4.2) | N/A |
aPD: Parkinson disease.
bHC: heathy control.
cN/A: not applicable.
Patients with PD were labeled as either (1) TremorDocumented: tremor was documented in routine documentation, regardless of type or amplitude (78/142, 54.9%), or (2) NoTremorDocumented: no information regarding tremor in routine documentation (64/142, 45.1%). We compared the routine tremor documentation to a Tremor Occurrence Score (TOS) from smartwatch recordings of a 20-second task, during which participants remained seated in an armchair. The TOS is normalized, from 0=no tremor occurrence to 1=tremor occurrence with a clear frequency peak, with 0.5 representing the average TOS of healthy controls. Details on calculations can be found in
[ , ].Ethical Considerations
The SDS parent study has been registered (ClinicalTrials.gov NCT03638479) and approved by the ethical board of the University of Münster and the physician’s chamber of Westphalia-Lippe (reference 2018-328-f-S). All participants gave written informed consent, and data were pseudonymized.
Results
shows boxplots of the TOSs according to participants’ routine tremor documentation. Overall, 16 (25%) out of 64 patients in the NoTremorDocumented group had a TOS ≥0.75 (the median TOS in the TremorDocumented group) and an average amplitude of 0.07 g. Particularly, 10 (16%) patients in the NoTremorDocumented group had a clear tremor (TOS >0.88, amplitude >0.10 g). The TremorDocumented group had a TOS ≥0.75 and an average amplitude of 0.11 g. Overall, patients with a clear but low-amplitude tremor (TOS ≥0.75, amplitude <0.05 g) were 1.59 times less likely to have a documented tremor (NoTremorDocumented) than those with a nonsubtle tremor (TOS ≥0.75, amplitude >0.05 g).
Discussion
Smartwatches can capture clear tremors in certain patients with PD, wherein the tremor was not documented during routine neurological assessments. Generally, patients with a clear but low-amplitude tremor (<0.05 g) were 1.59 times less likely to have a documented tremor than those with a strong tremor. We hypothesize that the tremor may not have been documented during the examination because of its small amplitude and difficulty of being seen. Moreover, a few patients (10/64, 16%) in the NoTremorDocumented group showed a clear tremor with visible amplitudes (>0.10 g), possibly due to the tremor being unnoticed or absent during routine examination. Likewise, tremors may not always manifest during smartwatch-based data capture, ultimately affecting the findings’ reproducibility.
Nevertheless, we suggest that integrating smartwatch-based data capture into routine neurological assessments enhances tremor documentation by providing objective numbers on frequency and amplitude for biomarker analysis. Smartwatch integration would further enable improved longitudinal assessment at home. The findings are not suitable for assessing the potential of diagnostic improvements, as routine manual documentation was only compared to smartwatch-based data capture. The parent study is currently evaluating a larger patient cohort, including differential diagnosis, to evaluate the diagnostic accuracy by using machine learning and more detailed tremor features, other movement characteristics, and nonmotor symptoms [
].Acknowledgments
We acknowledge support from the Open Access Publication Fund of the University of Münster. We thank the Department of Neurology at the University Hospital Münster for integrating the study.
Conflicts of Interest
None declared.
Tremor Occurrence Score (TOS) and tremor characteristic calculation.
DOCX File , 14 KBReferences
- Varghese J, Alen CMV, Fujarski M, Schlake GS, Sucker J, Warnecke T, et al. Sensor validation and diagnostic potential of smartwatches in movement disorders. Sensors (Basel). Apr 30, 2021;21(9):3139. [FREE Full text] [CrossRef] [Medline]
- Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, et al. Technology in Parkinson's disease: challenges and opportunities. Mov Disord. Dec 2016;31(9):1272-1182. [FREE Full text] [CrossRef] [Medline]
- Dai H, Zhang P, Lueth T. Quantitative assessment of Parkinsonian tremor based on an inertial measurement unit. Sensors (Basel). Sep 29, 2015;15(10):25055-25071. [FREE Full text] [CrossRef] [Medline]
- Sigcha L, Pavón I, Costa N, Costa S, Gago M, Arezes P, et al. Automatic resting tremor assessment in Parkinson's disease using smartwatches and multitask convolutional neural networks. Sensors (Basel). Jan 04, 2021;21(1):291. [FREE Full text] [CrossRef] [Medline]
- Sahin G, Halje P, Uzun S, Jakobsson A, Petersson P. Tremor evaluation using smartphone accelerometry in standardized settings. Front Neurosci. Aug 1, 2022;16:861668. [FREE Full text] [CrossRef] [Medline]
- ZhuParris A, de Goede AA, Yocarini IE, Kraaij W, Groeneveld GJ, Doll RJ. Machine learning techniques for developing remotely monitored central nervous system biomarkers using wearable sensors: a narrative literature review. Sensors (Basel). May 31, 2023;23(11):5243. [FREE Full text] [CrossRef] [Medline]
- Varghese J, Niewöhner S, Soto-Rey I, Schipmann-Miletić S, Warneke N, Warnecke T, et al. A smart device system to identify new phenotypical characteristics in movement disorders. Front Neurol. Jan 30, 2019;10:48. [FREE Full text] [CrossRef] [Medline]
- Reeder B, David A. Health at hand: a systematic review of smart watch uses for health and wellness. J Biomed Inform. Oct 2016;63:269-276. [FREE Full text] [CrossRef] [Medline]
- Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus statement on the classification of tremors. from the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Mov Disord. Jan 30, 2018;33(1):75-87. [FREE Full text] [CrossRef] [Medline]
- Vijayan V, Connolly JP, Condell J, McKelvey N, Gardiner P. Review of wearable devices and data collection considerations for connected health. Sensors (Basel). Aug 19, 2021;21(16):5589. [FREE Full text] [CrossRef] [Medline]
Abbreviations
PD: Parkinson disease |
SDS: Smart Device System |
TOS: Tremor Occurrence Score |
Edited by A Mavragani; submitted 26.07.23; peer-reviewed by D Parry, J Lopez-Rodriguez; comments to author 08.09.23; revised version received 13.10.23; accepted 07.02.24; published 20.03.24.
Copyright©Catharina Marie van Alen, Alexander Brenner, Tobias Warnecke, Julian Varghese. Originally published in JMIR Formative Research (https://formative.jmir.org), 20.03.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.